** Shares of Shanghai Junshi Biosciences 1877.HK drop 9.8% to HK$25.85, on course to snap four straight session of gains
** Shanghai-listed stock 688180.SS falls 2.7% to 37.60 yuan, on track for the biggest one-day pct decline since May 26, if losses hold
** The Chinese biopharmaceutical group plans to sell 41 million new H-shares to third-party investors, raising HK$1.04 billion ($132.51 million) for commercialising potential new-generation drugs and for investment in R&D technologies
** The new H-shares will be issued at HK$25.35 each, or 11.5% discount to Thursday's close of HK$28.65 per share
** Hong Kong's healthcare index .HSCIH and Hang Seng Biotech Index .HSHKBIO both climb 1.1%
** YTD, Hong Kong stock up 137.5%, Shanghai shares up 38.4%
($1 = 7.8487 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.